Medtronic (NYSE: MDT) announced the start of its Resolute Onyx Clinical Program in the United States, which will evaluate the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE